5th October, 2006
Panther Securities PLC ("Panther" or "the Company")
Directors' shareholding
The Company has been advised that earlier today Andrew Perloff, Executive
Chairman of the Company, and Harold Perloff granted 60,000 and 30,000 call
options to acquire ordinary shares in Panther at a price of 367.5p per share at
any time up to 5th October, 2011, respectively. John Perloff, John Doyle and
Simon Peters, all directors of the Company, were each granted 20,000 of the
above call options, with the balance being granted to certain other persons.
The interests of the above persons, other than the above grants of call
options, are as follows:
Director Ordinary Shares %
Andrew Perloff * 4,351,213 25.60
John Perloff 90,000 0.53
John Doyle 5,000 0.03
Simon Peters 22,500 0.13
* Andrew Perloff and his family trusts have beneficial interests in shares
owned by Portnard Limited, a company under their control, amounting to
7,737,336 Ordinary Shares, representing 45.52 per cent. of the issued share
capital of the Company.
In addition, Harold Perloff holds 895,000 Ordinary Shares, representing 5.27
per cent. of the issued share capital of the Company.
For further information:
Andrew Perloff, Panther Securities plc: 020 7278 8011
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.